The Elderly pp 28-41 | Cite as

Disorders of the Heart

  • W. J. MacLennan
  • A. N. Shepherd
  • I. H. Stevenson
Part of the Treatment in Clinical Medicine book series (TC MEDICINE)


Congestive cardiac failure is extremely common in old age, ankle oedema occurring in 22% of patients between 70 and 75 in general practice, and accounting for the fact that in those over 75, 18% are on diuretics, and 17% on digoxin (Currie et al. 1974; Law and Chalmers 1976). Treatment of the disorder does not differ qualitatively from that in younger individuals. However, changes in the renal function and in the electrolyte and metabolic status of old people modify their response to cardiac glycosides and diuretics, and increase the risk of side-effects.


Infective Endocarditis Diuretic Therapy Cardiac Glycoside Isosorbide Dinitrate Congestive Cardiac Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anturane Reinfarction Trial Research Group (1980) Sulphinpyrazone in the prevention of sudden death after myocardial infarction. New Engl J Med 302: 250–256CrossRefGoogle Scholar
  2. Burr ML, King S, Davies HEF, Pathy MS (1977) The effects of discontinuing long-term diuretic therapy in the elderly. Age Ageing 6: 38–45PubMedCrossRefGoogle Scholar
  3. Currie G, MacNeill RM, Walker JG, Barrie E, Mudie EW (1974) Medical and social screening of patients aged 70 to 72 by an urban general practice health team. Br Med J 2: 108–111PubMedCrossRefGoogle Scholar
  4. Dall JLC (1981) Observations on the action of digoxin. In: Caird FI, Grimley Evans J (eds) Advanced Geriatric medicine, Pitman, London, pp 56–61Google Scholar
  5. Greenblatt DJ, Duhme DW, Allen MD, Koch-Weser J (1977) Clinical toxicity of frusemide in hospitalised patients. A report from the Boston Collaborative Drug Surveillance Program. Am Heart J 94: 6–13PubMedCrossRefGoogle Scholar
  6. Hjalmarson A, Herlitz J, Malek I, Ryden L, Vedin A, Waldenstrom A, Wedel H, Elmfeldt D, Holmberg S, Nyberg G, Swedberg K, Waagstern F, Waldenstrom J, Wilhelmson L, Wilhelmson C (1981) Effect on mortality of metoprolol in acute myocardial infarction. Lancet 2: 823–826PubMedCrossRefGoogle Scholar
  7. Johnston GD, Kelly JG, McDevitt DG (1978) Do patients take digoxin? Br Med J 40: 1–7Google Scholar
  8. Law R, Chalmers C (1976) Medicines and elderly people: a general practice survey. Br Med J 1: 565–568PubMedCrossRefGoogle Scholar
  9. MacDonald A (1979) The management of infective endocarditis. Br J Hosp Med 21: 498–510Google Scholar
  10. McHaffie D, Purcell H, Mitchell-Heggs P, Guy A (1978) QJM 47: 401–402PubMedGoogle Scholar
  11. Norwegian Multicentre Study Group (1981) Timolol-induced reduction in mortality and infarction. New Engl J Med 304: 801–807CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • W. J. MacLennan
    • 1
  • A. N. Shepherd
    • 1
  • I. H. Stevenson
    • 2
  1. 1.University Department of MedicineNinewells Hospital and Medical SchoolDundeeScotland
  2. 2.Department of Pharmacology and Clinical PharmacologyNinewells Hospital and Medical SchoolDundeeScotland

Personalised recommendations